Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 440Lung Neoplasms 170Neoplasms 31Adenocarcinoma of Lung 27Neoplasm Metastasis 23Breast Neoplasms 23Prostatic Neoplasms 19Squamous Cell Carcinoma of Head and Neck 17Small Cell Lung Carcinoma 17Colorectal Neoplasms 13Melanoma 12Stomach Neoplasms 11Adenocarcinoma, Bronchiolo-Alveolar 11Pancreatic Neoplasms 10Ovarian Neoplasms 10Carcinoma, Renal Cell 10Head and Neck Neoplasms 9Urinary Bladder Neoplasms 8Recurrence 8Esthesioneuroblastoma, Olfactory 8Carcinoma, Squamous Cell 8Salivary Gland Neoplasms 7Esophageal Neoplasms 7NSCLC 6Carcinoma 6Advanced Non-Small Cell Lung Cancer 6Sarcoma 5Pleural Effusion, Malignant 5Parkinson Disease 4, Autosomal Dominant Lewy Body 5Carcinoma, Transitional Cell 5

Interventions

Megestrol Acetate 2remune 1ostarine 1nabilone 1clazakizumab 1anamorelin 1Sodium Chloride 1Radiotherapy 1Omacor 1Melatonin 1Infliximab 1Ibuprofen 1Exercise 1Enteral Nutrition 1Docetaxel 1Deuterium Oxide 1Deuterium 1Clarithromycin 1Caseins 1Carnitine 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cachexia × Docetaxel × Thoracic × Clear all
NCT00040885 2016-12-07

Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)

Alliance for Clinical Trials in Oncology

Phase 3 Completed
67 enrolled
Thoracic

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡